CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma

J Jiaojiao Xu Z Zhe Li Q Qinli Tong S Sihang Zhang J Jianchen Fang A Aihua Wu G Guoguang Wei C Chen Zhang (Shenzhen Institute for Quantum Science and Engineering, Department of Chemistry, and Department of Physics) S Sheng Yu B Binbin Zheng H Hongzheng Lin X Xueling Liao Z Zeyu Xiao (Department of Pharmacology and Chemical Biology, Institute of Molecular Medicine, Collaborative Innovation Center for Clinical and Translational Science by Chinese Ministry of Education & Shanghai) W Wei Lu

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 21, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (14)

J

Jiaojiao Xu

Z

Zhe Li

Q

Qinli Tong

S

Sihang Zhang

J

Jianchen Fang

A

Aihua Wu

G

Guoguang Wei

C

Chen Zhang

Shenzhen Institute for Quantum Science and Engineering, Department of Chemistry, and Department of Physics

S

Sheng Yu

B

Binbin Zheng

H

Hongzheng Lin

X

Xueling Liao

Z

Zeyu Xiao

Department of Pharmacology and Chemical Biology, Institute of Molecular Medicine, Collaborative Innovation Center for Clinical and Translational Science by Chinese Ministry of Education & Shanghai

W

Wei Lu